» Articles » PMID: 12477714

The Transcriptional Co-activators CREB-binding Protein (CBP) and P300 Play a Critical Role in Cardiac Hypertrophy That is Dependent on Their Histone Acetyltransferase Activity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Dec 13
PMID 12477714
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

The CBP and p300 proteins are transcriptional co-activators that are involved in a variety of transcriptional pathways in development and in response to specific signaling pathways. We have previously demonstrated that the ability of both these factors to stimulate transcription is greatly enhanced by treatment of cardiac cells with the hypertrophic agent phenylephrine (PE). Here, we show that inhibition of either CBP or p300 with antisense or dominant negative mutant constructs inhibits PE-induced hypertrophy as assayed by atrial naturetic protein production, cardiac cell protein:DNA ratio and cell size. Furthermore, we show that overexpression of CBP or p300 can induce hypertrophy and that this effect requires their histone acetyltransferase (HAT) activity. Moreover, we show that PE can directly enhance CBP HAT activity and that artificial enhancement of HAT activity is sufficient to induce hypertrophy. Hence, CBP and p300 play an essential role in hypertrophy induced by PE, and this effect is mediated via PE-induced enhancement of their HAT activity. This is the first time a role for these factors, and their HAT activity, in hypertrophy has been directly demonstrated.

Citing Articles

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening.

Lv J, Chen Q, Wang J, Guo N, Fang Y, Guo Q Nucleic Acids Res. 2024; 53(2.

PMID: 39657728 PMC: 11754730. DOI: 10.1093/nar/gkae1176.


Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development.

Caturano A, Vetrano E, Galiero R, Salvatore T, Docimo G, Epifani R Rev Cardiovasc Med. 2024; 23(5):165.

PMID: 39077592 PMC: 11273913. DOI: 10.31083/j.rcm2305165.


Progress and Challenges of Understanding Cardiorenal Syndrome Type 3.

Neres-Santos R, Armentano G, da Silva J, Falconi C, Carneiro-Ramos M Rev Cardiovasc Med. 2024; 24(1):8.

PMID: 39076878 PMC: 11270482. DOI: 10.31083/j.rcm2401008.


Chromatin modifiers in human disease: from functional roles to regulatory mechanisms.

Nie Y, Song C, Huang H, Mao S, Ding K, Tang H Mol Biomed. 2024; 5(1):12.

PMID: 38584203 PMC: 10999406. DOI: 10.1186/s43556-024-00175-1.


Cross-Tissue Single-Nucleus RNA Sequencing Discovers Tissue-Resident Adipocytes Involved in Propanoate Metabolism in the Human Heart.

Das S, Kar A, Rajkumar S, Lee S, Alvarez M, Pietilainen K Arterioscler Thromb Vasc Biol. 2023; 43(10):1788-1804.

PMID: 37409528 PMC: 10538422. DOI: 10.1161/ATVBAHA.123.319358.